1. Home
  2. RLAY vs MATH Comparison

RLAY vs MATH Comparison

Compare RLAY & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.48

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$2.40

Market Cap

145.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
MATH
Founded
2015
2015
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
145.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RLAY
MATH
Price
$8.48
$2.40
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
2.3M
76.0K
Earning Date
11-06-2025
12-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.41
Revenue
$8,355,000.00
$44,567,257.00
Revenue This Year
$20.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.93
Revenue Growth
N/A
165.86
52 Week Low
$1.78
$0.99
52 Week High
$9.04
$4.17

Technical Indicators

Market Signals
Indicator
RLAY
MATH
Relative Strength Index (RSI) 64.38 36.08
Support Level $7.95 $2.30
Resistance Level $9.04 $3.04
Average True Range (ATR) 0.50 0.21
MACD 0.02 -0.05
Stochastic Oscillator 69.06 12.20

Price Performance

Historical Comparison
RLAY
MATH

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

Share on Social Networks: